·¬ΗΡΙηΗψapp

Meeting Coverage

IAC

International AIDS Conference

Switching to Two-Drug HIV Regimen Just as Effective as Three-Drug Approach

Dolutegravir-based ART also led to less weight gain

IAC over a photo of Messe MΓΌnchen in Convention center in Munich, Germany

Latest IAC Meeting Coverage

Antiretroviral Abacavir Linked With Cardiovascular Events in REPRIEVE Trial

Clinicians should consider other options for ART, researcher says

July 28, 2024
Single HIV RNA Test Delivered False Positives With Long-Acting Cabotegravir PrEP

Findings highlight performance gaps in current HIV testing guidelines, expert says

July 26, 2024
Long-Acting Cabotegravir Appears Safe in Pregnancy

Maternal, neonatal outcomes are similar to background rates, analysis finds

July 25, 2024
'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV

New case suggests HIV cure can be achieved independent of stem cell transplant donor CCR5 status

July 25, 2024
Twice-Yearly Injection Yields Zero HIV Infections for High-Risk Women in Trial

Questions remain about its affordability, safety in pregnancy, experts say

July 24, 2024
Two Tests Better Than One for Detecting Anal Cancer in People With HIV

Combination testing also tied to fewer referrals for further diagnostics

July 23, 2024
Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections

Head-to-head comparison in ALLIANCE trial favors use over dolutegravir-based combination

August 3, 2022
Dual Therapy Holds Its Own in Treatment-Naive HIV

ANDES study shows less expensive therapy to be a "safe and well-tolerated" option

August 2, 2022
Symposium on Monkeypox Stigma Interrupted by Protesters

International experts advocate for accurate, timely information, while minimizing discrimination

August 2, 2022
Activists Crash AIDS Meeting, Protest for Better Access to Antiretrovirals

Demonstrators used their time at the convention center to endorse the "U = U" message

August 1, 2022
People With Advanced AIDS Benefit From Dolutegravir Treatment

Trial in Brazil offers hope for "late-presenter HIV patients"

July 31, 2022
Durable Long-term Results With Dolutegravir for HIV Suppression

SIMPL'HIV and NAMSAL trial data support WHO backing of dolutegravir, expert says

July 31, 2022
Two More Patients With HIV Surviving Without Antiretrovirals

Functional cures now seen in 5 patients

July 29, 2022
Post-Exposure Doxycycline Reduces STIs

Incidence of gonorrhea, chlamydia, and syphilis more than halved

July 29, 2022